Ceo Frank Jaksch

Online opportunities — not loss of big account — drove finished products shift, ChromaDex CEO claims

21-Aug-2017 By Hank Schultz

A shift in market dynamics — not a legal dispute with a key customer — is what drove ChromaDex to try for a second time the finished products route for one of its branded ingredients.

Niagen continues to push ChromaDex forward, but big debt payment delays profitability breakthrough

12-Aug-2016 By Hank Schultz

ChromaDex reported record sales for its second quarter driven mostly by sales of its Niagen ingredient.

ChromaDex revenue hits record as ingredient sales bring company close to profitability

17-Aug-2015 By Hank Schultz

Branded dietary ingredient supplier ChromaDex reported record revenue in its second quarter 2015 earnings statement. It was the fifth consecutive quarter in which the company reached a new earnings plateau.

ChromaDex bolsters IP protection around pTeroPure with memory, sun damage patents

26-Nov-2014 By Hank Schultz

ChromaDex has bolstered the IP protection around pTeroPure, one of its branded ingredients, with the announcement of two patents relating to pterostilbene, which are the second and third patents granted to the company on the ingredient.

Study shows potential for D-tagatose as sports nutrition ingredient

30-Jul-2013 By Hank Schultz

D-tagatose, an alternative sweetener that has drifted at the periphery of commercial viability for more than a decade, may have a new lease on life because of its blood sugar management properties, according to a study conducted by ChromaDex.

Chromadex sells BluScience retail supplement line to Canadian marketing firm

26-Feb-2013 By Hank Schultz

Chromadex has announced the sale of its BluScience retail line of supplements to NeutriSci International, a private nutraceutical and cosmetic product marketing and brand development firm based in Calgary, Alberta.

New pterostilbene ingredient claimed to be superior to resveratrol

02-Apr-2010 By Guy Montague-Jones

ChromaDex is launching an ingredient with similar properties to resveratrol having obtained commercial rights to the biological compound from the University of Mississippi and the Agriculture Research Service (ARS).

Antioxidants-by-fermentation: One step closer to market

12-Jun-2009 By Lorraine Heller

ChromaDex has received a grant to further develop a technology that can create anthocyanins via fermentation, which the firm says will allow it to test whether the process is viable on a commercial scale.